Mobidiag Gets CE Marks for Two Tests

Apr 19, 2018

|

NEW YORK (GenomeWeb) – Mobidiag today said that it has received CE marking for its Amplidiag CarbaR+MCR test and the Novidiag Bacterial GE+ test.

Amplidiag CarbaR+MCR is for detecting the main carbapenemase-producing organisms and colistin resistance markers in one test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Keep Them or Not?

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

Dunno Whose It Is

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

Knowing Risk From a Young Age

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

Science Translational Medicine Paper Finds Drug Combo Boosts KRAS Inhibitor Efficacy in Lung Cancer

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Featured White Papers

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

Multiplexed Infectious Disease Analysis

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Sep

25

Featured Webinar

Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

CAR T-cell therapy is an innovative form of immunotherapy that is finding increasing use for the management of blood cancers.

Oct

08

Featured Webinar

Integration of Single Cell and Spatially Resolved Methods for Understanding Neurodegeneration in ALS

This webinar will discuss a study that used spatial transcriptomics to gain insight into the molecular mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Oct

10

Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Menu